U.S. Uterine Fibroid Market Accruals Reach Up to USD 39,993.2 Million by 2022 at 3.24% of CAGR; Declares MRFR
Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman's uterus. These are also known as leiomyoma or myomas. The U.S. Uterine Fibroids Market is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.